| scholarly article | Q13442814 |
| P2093 | author name string | Franck J D Mennechet | |
| Gilles Uzé | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 4417-23 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells | |
| P478 | volume | 107 |
| Q35992866 | A mechanistic role for type III IFN-λ1 in asthma exacerbations mediated by human rhinoviruses |
| Q40525273 | A novel kefir product (PFT) activates dendritic cells to induce CD4+T and CD8+T cell responses in vitro |
| Q37947594 | A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects. |
| Q35134310 | Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells |
| Q28650908 | Advanced molecular surveillance of hepatitis C virus |
| Q45857655 | Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1. |
| Q47156382 | Antifungal Activity of Plasmacytoid Dendritic Cells and the Impact of Chronic HIV Infection. |
| Q36425910 | Antitumor activity of type I and type III interferons in BNL hepatoma model |
| Q39241303 | Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients. |
| Q83316443 | Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis |
| Q94418586 | Changes in Serum Levels of Type-III Interferons in Ankylosing Spondylitis Treated With Tumor Necrosis Factor-Alpha Inhibitors |
| Q36897571 | Changes in inflammatory cytokine networks in myasthenia gravis |
| Q40505925 | Combination of Adt-O1Manisa and Ad5-boIFNλ3 induces early protective immunity against foot-and-mouth disease in cattle |
| Q24642027 | Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity |
| Q39176570 | Contribution of type III interferons to antiviral immunity: location, location, location |
| Q35116303 | Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? |
| Q37754644 | Dendritic cell-based therapy in Type 1 diabetes mellitus |
| Q34750577 | Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response. |
| Q26700107 | Dengue virus infection induces interferon-lambda1 to facilitate cell migration |
| Q28260203 | Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines |
| Q53243459 | Dexamethasone decreases IL-29 expression in house dust mite-stimulated human bronchial epithelial cells. |
| Q41831511 | Effect of human interferon-λ1 recombinant adenovirus on a gastric cancer orthotopic transplantation model |
| Q36694881 | Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid |
| Q33605263 | Epithelium: at the interface of innate and adaptive immune responses |
| Q56790230 | Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals |
| Q57456334 | Genetic Architecture of Adaptive Immune System Identifies Key Immune Regulators |
| Q34093766 | Genetic variants of innate immune receptors and infections after liver transplantation. |
| Q85112486 | Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection |
| Q34147621 | Genetic variations in IL28B and allergic disease in children |
| Q36734178 | Highly heterogeneous, activated, and short-lived regulatory T cells during chronic filarial infection |
| Q53019296 | Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. |
| Q24313193 | IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells |
| Q37867104 | IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use. |
| Q37997043 | IFN-λ and IgE-mediated allergic disease: a potential future role? |
| Q34147632 | IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection |
| Q27308880 | IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production. |
| Q35675878 | IFN-λ: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research |
| Q37917252 | IFN-λs |
| Q42247379 | IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis. |
| Q41470344 | IFNλ Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism |
| Q33525565 | IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE) |
| Q41863615 | IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease |
| Q34682206 | IL-28B is a key regulator of B- and T-cell vaccine responses against influenza |
| Q37690200 | IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients |
| Q35042843 | IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection |
| Q47130188 | Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway. |
| Q36897372 | Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus |
| Q34992701 | Impact and regulation of lambda interferon response in human metapneumovirus infection |
| Q42133572 | Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection |
| Q45358158 | Impact of interleukin-28B genotype on in vitro and in vivo systems of hepatitis C virus replication |
| Q27010065 | Induction and function of type I and III interferon in response to viral infection |
| Q58707479 | Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update |
| Q41919675 | Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset |
| Q47143961 | Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs. |
| Q47141979 | Interferon Lambda Genetics and Biology in Regulation of Viral Control |
| Q35865362 | Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection |
| Q30661545 | Interferon induction and function at the mucosal surface |
| Q37352688 | Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses |
| Q48175284 | Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation. |
| Q21296797 | Interferon lambda: a new sword in cancer immunotherapy |
| Q34433087 | Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV. |
| Q35154826 | Interferon lambdas: the next cytokine storm |
| Q35557898 | Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity |
| Q28238963 | Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses |
| Q27655546 | Interferon- Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family |
| Q34047500 | Interferon-λ in HCV Infection and Therapy |
| Q27013848 | Interferon-λ in the context of viral infections: production, response and therapeutic implications |
| Q92761688 | Interferon-λ orchestrates innate and adaptive mucosal immune responses |
| Q58694999 | Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese |
| Q42369758 | Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract |
| Q38064651 | Interferon-λs: special immunomodulatory agents and potential therapeutic targets. |
| Q37689877 | Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon |
| Q42200313 | Interleukin-28B dampens airway inflammation through up-regulation of natural killer cell-derived IFN-γ. |
| Q39747657 | Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis |
| Q53327148 | Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways. |
| Q36633252 | Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis |
| Q38668279 | Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection. |
| Q38974225 | Lambda Interferons: New Cytokines with Old Functions |
| Q58613914 | Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control |
| Q91670701 | Macrophage Coordination of the Interferon Lambda Immune Response |
| Q28269054 | Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes |
| Q28258808 | Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29) |
| Q35407009 | Modulation of the function of dendritic cells in adolescents with chronic HBV infection by IFN-λ1 |
| Q49915030 | Mutation of IFNLR1, an interferon lambda receptor 1, is associated with autosomal-dominant non-syndromic hearing loss |
| Q33612256 | New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells |
| Q37809070 | Novel Findings in Drug-Induced Dendritic Cell Tolerogenicity |
| Q27014714 | Overlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functions |
| Q39396346 | Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus type-1 mono-infection and co-infection with hepatitis C virus |
| Q52680553 | Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry. |
| Q38320081 | Role of Interferon-λ in Allergic Asthma. |
| Q37362240 | Role of viral and host factors in interferon based therapy of hepatitis C virus infection |
| Q27486637 | T cells with regulatory activity in hepatitis C virus infection: what we know and what we don't |
| Q54441842 | The effect of IL-28A on human cord blood CD4+ T cells. |
| Q38514365 | The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections |
| Q38535876 | The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation |
| Q38956578 | The role of IL-29 in immunity and cancer. |
| Q37261750 | The role of transposable elements in the regulation of IFN-lambda1 gene expression |
| Q39806423 | Treatment of hepatitis C infections with interferon: a historical perspective |
| Q36974002 | Tregs are regulated by cytokines: implications for autoimmunity |
| Q38281570 | Type I IFN family members: similarity, differences and interaction |
| Q38780088 | Type I and III IFNs Produced by Plasmacytoid Dendritic Cells in Response to a Member of the Flaviviridae Suppress Cellular Immune Responses. |
| Q36630086 | Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells |
| Q34262131 | Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector. |
| Q38577688 | Type III interferons (IFNs): Emerging Master Regulators of Immunity |
Search more.